InMed Pharmaceuticals Cash Flow Statement (2019-2026) | INM

Cash Flow Statement Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-2.97M-4.28M-3.48M-7.87M-3.51M-2.10M-2.00M-0.34M-2.54M-1.48M-1.72M-1.93M-1.68M-2.58M-0.05M-1.31M-1.73M-2.03M-0.17M
Depreciation and Depletion (Quarter)
0.00M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M
Share-based Compensation (Quarter)
0.22M0.11M0.21M0.20M0.18M0.12M0.07M0.05M0.04M0.03M0.02M0.06M0.04M0.03M0.02M644.00-0.01M0.02M0.03M0.02M
Gains from Investment Securities (Quarter)
-0.01M-550.000.07M-0.01M0.10M0.63M0.68M0.19M0.03M0.06M0.00M0.14M0.01M
Asset Writedowns and Impairment (Quarter)
0.58M-0.55M0.02M0.09M0.17M0.04M0.21M0.07M
Non-cash Items (Quarter)
0.04M0.19M0.15M0.18M0.08M0.14M0.10M0.07M0.05M0.16M0.11M
Cash from Operations (Quarter)
-2.01M-2.65M-3.53M-5.35M-4.05M-2.26M-2.71M-1.66M-0.66M-2.17M-1.85M-1.93M-1.03M-1.83M-2.50M-1.66M-1.78M-1.61M-2.38M-1.70M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.10M0.09M0.09M0.10M0.09M0.09M0.10M0.10M0.09M0.08M0.08M0.08M0.10M0.10M0.08M
Depreciation & Amortization (CF) (Quarter)
0.03M0.03M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.06M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M
Change in Working Capital
Change in Receivables (Quarter)
-0.06M0.00M-638.000.02M0.02M-0.07M0.09M0.09M0.11M-0.09M0.21M-0.17M0.15M-0.07M-0.02M0.11M0.10M-0.12M-0.16M
Change in Inventory (Quarter)
0.43M1.07M-0.14M-0.17M-0.28M0.02M-0.39M-0.22M0.45M0.09M-0.02M-0.12M-0.29M0.15M-0.07M0.13M
Change in Accured Expenses (Quarter)
0.58M-0.47M0.77M-0.49M-0.62M-0.16M-0.35M-0.08M-0.22M-0.56M0.24M-0.10M0.47M-0.64M0.36M-0.07M0.10M-0.27M-0.06M0.11M
Other Working Capital Changes (Quarter)
-0.37M-0.63M0.64M0.32M-0.33M-0.44M0.46M-0.44M-0.28M0.09M-0.10M0.27M-0.11M-0.10M-0.11M-0.11M-0.11M0.44M-0.04M
Investing Activities
Capital Expenditures (Quarter)
0.25M-0.21M0.00M0.03M2.00
Sales of Property, Plant and Equipment (Quarter)
Change in Acquisitions & Divestments (Quarter)
0.02M0.02M-431.000.02M0.00M0.02M0.00M0.02M0.00M0.02M
Cash from Investing Activities (Quarter)
-0.25M0.31M-0.00M-0.73M-0.13M-0.03M-2.00
Financing Activities
Other financing activities (Quarter)
0.08M1.12M0.18M0.49M0.57M0.68M0.06M0.03M0.19M0.06M0.02M0.62M0.14M
Cash from Financing Activities (Quarter)
-0.08M10.88M-0.84M-0.03M5.05M5.43M5.32M-0.06M176.000.84M0.34M2.92M8.17M-0.14M0.23M
Additional items
Exchange Rate Effect (Quarter)
Change in Cash (Quarter)
-2.09M7.98M-4.06M-5.38M0.28M3.17M2.10M-1.85M-0.69M-2.17M2.80M-1.93M-1.03M-0.99M-2.16M1.26M6.40M-1.74M-2.38M-1.46M
Free Cash Flow (Quarter)
-2.01M-2.90M-3.32M-5.35M-4.05M-2.26M-2.71M-1.66M-0.69M-2.17M-1.85M-1.93M-1.03M-1.83M-2.50M-1.66M-1.78M-1.61M-2.38M-1.70M
Net Cash Flow (Quarter)
-2.09M7.98M-4.06M-5.38M0.28M3.17M2.60M-1.85M-0.69M-2.17M-1.85M-1.93M-1.03M-0.99M-2.16M1.26M6.40M-1.74M-2.38M-1.46M